Evidence map›Paper›PMID 28590441›Full record

SynthesisMolecules (Basel, Switzerland)2017

Origins, Phytochemistry, Pharmacology, Analytical Methods and Safety of Cortex Moutan (Paeonia suffruticosa Andrew): A Systematic Review.

Zhiqiang Wang, Chunnian He, Yong Peng, Feihu Chen, Peigen Xiao

2 registry-linked trialsAbstract readSystematic Review
In one paragraph

Synthesis in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05664906 phase1 / phase2unknown statusnot on this mapstarted 2023, after this paper: background citation

Evaluating Efficacy and Safety of Chinese Medicine Oral Rinse in Treating and Preventing Irradiated Oral Mucositis in Head-and-Neck Cancer Patients - a Pilot Trial

TypeinterventionalSponsorChinese University of Hong KongRan2023 to 2024Enrolled40ConditionsHead and Neck Neoplasms, Oral Mucositis (Ulcerative) Due to Radiation, Chinese Medicine Oral RinseArmsChinese Medicine Oral Rinse Formula-I (CMORF-I), Standard Care, Placebo
NCT07693374 nawithdrawnnot on this mapstarted 2022, after this paper: background citation

A Chinese Medicinal Component Relieves the Chemotherapy-induced Peripheral Neuropathy and the Relating Changes of Mitochondria Function in Dorsal Root Ganglion: Basic and Clinical Research

TypeinterventionalSponsorTaiwan Municipal An-Nan Hospital-China Medical UniversityRan2022 to 2025Enrolled0ConditionsBreast Cancer, Chemotherapy-induced Peripheral Neuropathy (CIPN)ArmsMoutan cortex, sham moutan cortex
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Comprehensive comparison of different parts ofFrontiers in plant science · 2023
    Article
  20. Anti-Fungal Activity ofACS omega · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhiqiang WangSchool of Pharmacy, Anhui Medical University, Hefei 230032, China. wzqwillis1016@gmail.com.
Chunnian HeInstitute of Medicinal Plant Development, Chinese Academy of Medical Science, Peking Union Medical College, Beijing 100193, China. cnhe@implad.ac.cn.
Yong PengInstitute of Medicinal Plant Development, Chinese Academy of Medical Science, Peking Union Medical College, Beijing 100193, China. ypeng@implad.ac.cn.
Feihu ChenSchool of Pharmacy, Anhui Medical University, Hefei 230032, China. cfhchina@sohu.com.
Peigen XiaoInstitute of Medicinal Plant Development, Chinese Academy of Medical Science, Peking Union Medical College, Beijing 100193, China. xiaopg@public.bta.net.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cortex Moutan (CM), a well-known traditional Chinese medicine, is commonly used for treating various diseases in China and other eastern Asian countries. Recorded in Pharmacopeias of several countries, CM is now drawing increasing attention and under extensive studies in various fields. Phytochemical studies indicate that CM contains many valuable secondary metabolites, such as monoterpene glycosides and phenols. Ample evidence from pharmacological researches suggest that CM has a wide spectrum of activities, such as anti-inflammatory, anti-oxidant, anti-tumor, anti-diabetic, cardiovascular protective, neuroprotective, hepatoprotective effects. Moreover, various analytical methods were established for the quality evaluation and safety control of CM. This review synopsizes updated information concerning the origins, phytochemistry, pharmacology, analytical method and safety of CM, aiming to provide favorable references for modern CM research and application. In conclusion, continuing pharmacological investigations concerning CM should be conducted to unravel its pharmacological mechanisms. Further researches are necessary to obtain comprehensive and applicable analytical approach for quality evaluation and establish harmonized criteria of CM.

Indexed as

Chromatography, LiquidDrugs, Chinese HerbalEthnopharmacologyHumansMass SpectrometryPaeoniaPhytochemicalsDrugs, Chinese Herbalmoutan cortexPhytochemicalsCortex MoutanoriginspharmacologyphytochemistrysafetyTraditional Chinese Medicine

Identifiers

PMID28590441
PMCPMC6152737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.